The current valuation score of X T L Biopharmaceuticals Ltd is 9.97, ranking 1 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.83, which is -100.00% below the recent high of 0.00 and -1161.29% above the recent low of -48.26.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.